Efficacy of risperidone for treating patients with behavioral and psychological symptoms of dementia

International Psychogeriatrics

Volumn 16, Issue 1, 2004, Pages 107-115

  Wancata, Johannes ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dementia; Non cognitive symptoms; Primary care; Risperidone

Indexed keywords

RISPERIDONE;

AGED; ARTICLE; AUSTRIA; BEHAVIOR DISORDER; BEHAVIOR SYMPTOM; CLINICAL TRIAL; DEMENTIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; GENERAL PRACTITIONER; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NAUSEA; OPEN STUDY; PSYCHOLOGICAL SYMPTOM; PSYCHOPHARMACOTHERAPY; SEDATION; SIDE EFFECT; SYMPTOM; VOMITING; XEROSTOMIA;

AGED; ANTIPSYCHOTIC AGENTS; DEMENTIA; HUMANS; MENTAL DISORDERS; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISPERIDONE; SEVERITY OF ILLNESS INDEX;

EID: 3042810010     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610204000122     Document Type: Article

References (16)

1. American Psychiatric Association (1997). Work Group on Alzheimers' Disease and Related Dementias. Practice guidelines for treatment of patients with Alzheimers' Disease and other dementias in late life. American Journal of Psychiatry, 154 (Suppl. 5), 1-39.
2. Bancher, C., Croy, A., Dal Bianco, P., et al. (1998). Oesterreichisches Alzheimer-Krankheit-Konsensuspapier. Neuropsychiatrie, 12, 126-167.
3. Brodaty, H., Ames, D., Snowdon, J., et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis in dementia. Journal of Clinical Psychiatry, 64, 134-143.
4. Burns, A., Jacoby, R., and Levy, R. (1990). Psychiatric phenomena in Alzheimer's disease. British Journal of Psychiatry, 157, 72-94.
5. De Deyn, P. P., Rabheru, K., Rasmussen, A., et al. (1999). A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology, 53, 946-955.
6. Diwan, S., and Phillips, V. A. (2001). Agitation and dementia-related problem behaviors and case management in long-term care. International Psychogeriatrics, 13, 5-21.
7. Finkel, S. I., Costa e Silva, J., Cohen, G., Miller, S., and Sartorius, N. (1996). Behavioral and psychological signs and symptoms of dementia: a consensus statement of current knowledge and implications for research and treatment. International Psychogeriatrics, 8 (Suppl. 3), 497-500.
8. Fortinsky, R., Kercher, K., and Burant, C. (2002). Measurement and correlates of family caregiver self-efficacy for managing dementia. Aging and Mental Health, 6, 153-160.
9. Goldberg, R., and Goldberg, J. (1997). Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience. International Psychogeriatrics, 9, 65-68.
10. Haupt, M., and Kurz, A. (1993). Predictors of nursing home placement in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry, 8, 741-747.
11. Holroyd, S. (2000). Hallucinations and delusions in dementia. International Psychogeriatrics, 12 (Suppl. 1), 113-117.
12. Katz, I. R., Jeste, D. V., Mintzer, J. E., et al. (1999). Comparison of Risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomised, double-blind trial. Journal of Clinical Psychiatry, 60, 107-115.
13. Wancata, J., Hajji, M., and Windhaber, J. (1999). Epidemiologie und Versorgung Demenzkranker. Neuropsychiatrie, 13, 122-132.
14. Wenger, G., Scott, A., and Seddon, D. (2002). The experience of caring for older people with dementia in a rural area using services. Aging and Mental Health, 6, 30-38.
15. World Health Organization (1993). The ICD-10 Classification of Mental and Behavioural Disorders: Psychiatric Adaption. Geneva: WHO.
16. Wragg, R., and Jeste, D. (1989). Overview of depression and psychosis in Alzheimer's disease. American Journal of Psychiatry, 146, 577-587.